01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

ased plasmids complexed to cationic liposomes for gene
therapy of human prostate cancer. Cancer Res 55, 2366-
2372.
Vieweg J, Rosenthal F, Bannerji R, Heston W, Fair W,
Gansbacher B, and Gilboa E (1994) Immunotherapy of
prostate cancer in the Dunning rat model: Use of cytokine
gene modified tumor vaccines. Cancer Res 54: 1760-1765.
Vikkula M, Boon LM, Carraway III KL, Calvert JT, Diamonti
AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML,
Cantley LC, Mulliken JB, and Olsen BR (1996) Vascular
dysmorphogenesis caused by an activating mutation in the
receptor tyrosine kinase TIE2. Cell 87, 1181-1190.
Vile RG and Russell SJ (1995) Retroviruses as vectors. Br Med
Bull 51, 12-30.
Villarreal FJ, Lee AA, Dillmann WH, Giordano FJ (1996)
Adenovirus-mediated overexpression of human transforming
growth factor-β1 in rat cardiac fibroblasts, myocytes and
smooth muscle cells. Mol Cell Cardiol 28, 735-742.
Vincent AJ, Esandi MC, Avezaat CJ, Vecht CJ, Sillevis Smitt P,
van Bekkum DW, Valerio D, Hoogerbrugge PM, Bout A
(1997) Preclinical testing of recombinant adenoviral herpes
simplex virus-thymidine kinase gene therapy for central
nervous system malignancies. Neurosurgery 41, 442-451.
Voeller HJ, Sugars LY, Pretlow T, and Gelmann EP (1994) p53
mutations in human prostate cancer specimens. J Urol 151,
492-495.
Vogelstein B (1990) A deadly inheritance. Nature 348, 681-682.
Vogelstein B and Kinzler K (1992) p53 function and
dysfunction. Cell 70: 523-526.
von der Leyden HE, Gibbons GH, Morishita R, Lewis NP,
Zhang L., Nakajima M, Kaneda Y, Cooke JP, and Dzau VJ
(1995) Gene therapy inhibiting neointimal vascular lesion: in
vivo transfer of endothelial cell nitric oxide synthase gene.
Proc Natl Acad Sci USA 92, 1137-1141.
Wachtel SR, Bencsics C, Kang UJ (1997) Role of aromatic Lamino
acid decarboxylase for dopamine replacement by
genetically modified fibroblasts in a rat model of Parkinson's
disease. Neurochem 69, 2055-2063.
Wagner AJ, Kokontis JM, and Hay N (1994) Myc-mediated
apoptosis requires wild-type p53 in a mannert independent of
cell cycle arrest and ability of p53 to induce p21 waf1/cip1 .
Genes Dev 8, 2817-2830.
Wagner E, Cotten M, Foisner R, Birnstiel ML (1991)
Transferrin-polycation-DNA complexes: The effect of
polycations on the structure of the complex and DNA
delivery to cells. Proc Natl Acad Sci USA 88, 4255-4259.
Wagner E, Plank C, Zatloukal K, Cotten M, and Birnstiel ML
(1992a) Influenza virus hemagglutinin HA-2 N-terminal
fusogenic peptides augment gene transfer by transferrinpolylysine-DNA
complexes: Toward a synthetic virus-like
gene-transfer vehicle. Proc Natl Acad Sci USA 89, 7934-
7938.
Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler K,
Curiel DT, and Birnstiel ML (1992b) Coupling of adenovirus
to tranferrin-polylysine/DNA complexes greatly enhances
receptor-mediated gene delivery and expression of
transfected genes. Proc Natl Acad Sci USA 89, 6099-6103.
Boulikas: An overview on gene therapy
160
Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL,
Young NS, and Liu JM (1994) Phenotypic correction of
Fanconi anemia in human hematopoietic cells with a
recombinant adeno-associated virus vector . J Clin Invest
94, 1440-1448.
Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K,
Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB
(1993) Gene inoculation generates immune responses against
human immunodeficiency virus type 1. Proc Natl Acad Sci
USA 90, 4156-4160.
Wang C-Y and Huang L (1987) pH-sensitive immunoliposomes
mediate target-cell-specific delivery and controlled
expression of a foreign gene in mouse. Proc Natl Acad Sci
USA 84, 7851-7855.
Wang EH, Friedman PN, Prives C (1989) The murine p53
protein blocks replication of SV40 DNA in vitro by
inhibiting the initiation functions of SV40 large T antigen.
Cell 57, 379-392.
Wang J, Kim H-H, Yuan X, and Herrin DL (1997) Purification,
biochemical characterization and protein-DNA interactions
of the I-CreI endonuclease produced in Escherichia coli.
Nucleic Acids Res 25, 3767-3776.
Wang JM, Zheng H, Blaivas M, Kurachi K (1997) Persistent
systemic production of human factor IX in mice by skeletal
myoblast-mediated gene transfer: feasibility of repeat
application to obtain therapeutic levels. Blood 90, 1075-
1082.
Wang L, Zoppe M, Hackeng TM, Griffin JH, Lee KF, Verma IM
(1997) A factor IX-deficient mouse model for hemophilia B
gene therapy. Proc Natl Acad Sci USA 94, 11563-11566.
Wang NP, To H, Lee WH, Lee EY (1993) Tumor suppressor
activity of RB and p53 genes in human breast carcinoma
cells. Oncogene 8, 279-288.
Wang S and Vos J-M (1996) A hybrid herpesvirus infectious
vector based on Epstein-Barr virus and Herpes Simplex virus
type 1 for gene transfer into human cells in vitro and in vivo.
J Virol 70, 8422-8430.
Wang X, Zelenski NG, Yang J, Sakai J, Brown MS, Goldstein JL
(1996) Cleavage of sterol regulatory element binding
proteins (SREBPs) by CPP32 during apoptosis. EMBO J 15,
1012-1020.
Wang Y and Becker D (1997) Antisense targeting of basic
fibroblast growth factor and fibroblast growth factor
receptor-1 in human melanomas blocks intratumoral
angiogenesis and tumor growth. Nat Med 3, 887-893.
Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW (1994) A
regulatory system for use in gene transfer. Proc Natl Acad
Sci USA 91, 8180-8184.
Wang Z-Q, Auer B, Sting L, Berghammer H, Haidacher D,
Schweiher M, and Wagner EF (1995) Mice lacking ADPRT
and poly(ADP-ribosyl)ation develop normally but are
susceptible to skin disease. Genes Dev 9, 509-520.
Ward M, Richardson C, Piuoli P, Smith L, Podda S, Goff S,
Hesdorffer C, and Bank A (1994) Transfer and expression of
the human multiple drug resistance gene in human CD34 +
cells. Blood 84, 1408-1414.